Preserving Muscle Mass During GLP-1 Treatment: What the Science Actually Says

Losing weight on a GLP-1 medication like Ozempic or Wegovy can feel like a victory on the scale. But here is what many people discover only after the pounds start coming off: not all of that weight loss is fat. Some of it is muscle. And losing muscle is exactly the opposite of what you want if your goal is a healthier, more functional body.

The American College of Sports Medicine released updated guidelines in 2026 specifically addressing this problem. Their message was clear: if you are on a GLP-1 receptor agonist and you are not actively protecting your muscle mass, you are leaving results on the table and possibly setting yourself up for a weaker body underneath the smaller number on the scale.

Why GLP-1 Medications Pull Muscle Out of the Equation

The way GLP-1 medications work involves appetite suppression at a deep level. You eat less, you feel full faster, and your body gradually taps into stored energy. That process does not discriminate between fat and muscle tissue, especially when the calorie deficit is large or happens quickly.

Research published in journals like Obesity and the Journal of Clinical Endocrinology and Metabolism has documented that rapid weight loss on these medications can result in muscle accounting for up to 30 to 40 percent of total weight lost. That is a significant chunk of metabolically active tissue going out the window.

Muscle is not just about aesthetics. It is the engine that keeps your metabolism running, your bones strong, and your daily movements effortless. When muscle mass drops, so does your resting metabolic rate. You start burning fewer calories at rest than you did before. And the moment you go back to eating normally, the weight tends to come back as fat rather than muscle.

The ACSM 2026 Protocol: Protein and Resistance Training

The updated ACSM guidelines took direct aim at this issue. Their 2026 recommendations for individuals on GLP-1 therapy hinge on two non-negotiable pillars.

The first pillar is protein intake. The guidelines suggest a range of 1.6 to 2.2 grams of protein per kilogram of body weight daily for anyone attempting to preserve lean mass during active weight loss. To put that in practical terms, a person weighing 80 kilograms should aim for roughly 130 to 175 grams of protein every day. That sounds like a lot until you break it down across three meals: a breakfast with eggs and Greek yogurt, a lunch with chicken breast or legumes, and a dinner built around fish or lean beef.

Spreading protein evenly across the day matters as much as the total amount. The body can only absorb and utilize a certain amount per meal, roughly 25 to 40 grams. Hitting that window three times a day signals the muscles to hold on to their tissue even in a caloric deficit.

The second pillar is resistance training. ACSM now recommends at least two to three sessions per week of structured strength work for people on GLP-1 medications. These sessions do not need to be marathons. A solid 30 to 45 minutes targeting the major muscle groups, the legs, back, chest, and core, produces measurable results in preserving and even building lean tissue during weight loss.

Progressive overload remains the name of the game. That means gradually increasing the weight, reps, or sets over time so the muscles keep adapting. A person who does the same routine for months will stop seeing the muscle-preserving benefits.

What Happens When You Combine Both

When protein intake is dialed in and resistance training is consistent, the results are noticeably different from weight loss done through dieting alone. Studies tracking body composition in people combining both strategies with GLP-1 therapy show a much higher proportion of fat loss versus muscle loss. Some participants even report gaining muscle while the scale goes down, which is the ideal scenario for long-term health outcomes.

Beyond the numbers on the scale, there are quality-of-life differences. People who strength train during GLP-1 treatment report better energy levels, improved mood, steadier blood sugar control, and more mobility. Stronger muscles make everyday activities easier, from climbing stairs to carrying groceries. The benefits extend well beyond appearance.

Common Pitfalls to Avoid

One mistake people make is waiting too long to start strength training. They assume they should focus first on adjusting to the medication and the new eating patterns, then add exercise later. By that point, muscle loss may already be underway.

Another issue is underestimating how much protein is truly needed. Many people who think they are eating enough protein are still falling short of the 1.6 grams per kilogram threshold. Keeping a simple food diary for a few days, even with a rough estimate, can be an eye-opener.

Some individuals also make the error of focusing exclusively on cardio because they want to maximize calorie burn. Cardio has its place for heart health and endurance, but without resistance training, it does not protect muscle tissue. Both are necessary, but the strength work is the more critical piece for body composition.

A Realistic Starting Point

If you are on a GLP-1 medication and want to protect your muscle mass, here is a straightforward starting point. Calculate your protein target by multiplying your weight in kilograms by 1.6. That is your floor. Aim to hit that every day.

Then, find a form of resistance training you actually enjoy. Bodyweight squats, push-ups, and dumbbell rows are enough to get started. You do not need a gym membership or expensive equipment. Two sessions in week one, three in week two, and keep building from there.

For anyone who wants extra support in staying consistent with meals and movement while managing weight with a GLP-1 medication, the Ozempro app was built with exactly this challenge in mind. You can explore how it fits your routine by clicking here to take the quiz.

Keeping muscle intact during weight loss is one of the smartest things you can do for your body. The effort pays off not just now, but for years ahead.